Impaired Replication Capacity of Acute/Early Viruses in Persons Who Become HIV Controllers

被引:106
作者
Miura, Toshiyuki [1 ,2 ,3 ,4 ,5 ]
Brumme, Zabrina L. [1 ,2 ,6 ,7 ]
Brockman, Mark A. [1 ,2 ,6 ,7 ]
Rosato, Pamela [1 ]
Sela, Jennifer [1 ]
Brumme, Chanson J. [1 ]
Pereyra, Florencia [1 ,2 ]
Kaufmann, Daniel E. [1 ,2 ]
Trocha, Alicja [1 ,3 ]
Block, Brian L. [1 ,2 ]
Daar, Eric S. [8 ]
Connick, Elizabeth [9 ]
Jessen, Heiko [10 ]
Kelleher, Anthony D. [11 ]
Rosenberg, Eric [1 ,2 ]
Markowitz, Martin [12 ]
Schafer, Kim [13 ]
Vaida, Florin [14 ]
Iwamoto, Aikichi [4 ,5 ]
Little, Susan [13 ]
Walker, Bruce D. [1 ,2 ,3 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Boston, MA USA
[2] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA
[3] Howard Hughes Med Inst, Chevy Chase, MD USA
[4] Univ Tokyo, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan
[5] Univ Tokyo, Inst Med Sci, Tokyo, Japan
[6] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada
[7] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada
[8] Univ Calif Los Angeles, Harbor Med Ctr, Los Angeles Biomed Res Inst, David Geffen Sch Med, Torrance, CA 90509 USA
[9] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA
[10] Jessen Praxis, Berlin, Germany
[11] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW, Australia
[12] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[13] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[14] Univ Calif San Diego, Div Biostat & Bioinformat, Dept Family & Prevent Med, San Diego, CA 92103 USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
T-LYMPHOCYTE EPITOPES; REVERSE-TRANSCRIPTASE; ESCAPE MUTATIONS; IN-VITRO; ANTIRETROVIRAL THERAPY; ELITE SUPPRESSORS; VIRAL LOAD; EX-VIVO; RESISTANCE MUTATIONS; DISEASE PROGRESSION;
D O I
10.1128/JVI.00286-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) controllers maintain viremia at <2,000 RNA copies/ml without antiretroviral therapy. Viruses from controllers with chronic infection were shown to exhibit impaired replication capacities, in part associated with escape mutations from cytotoxic-T-lymphocyte (CTL) responses. In contrast, little is known about viruses during acute/early infection in individuals who subsequently become HIV controllers. Here, we examine the viral replication capacities, HLA types, and virus sequences from 18 HIV-1 controllers identified during primary infection. gag-protease chimeric viruses constructed using the earliest postinfection samples displayed significantly lower replication capacities than isolates from persons who failed to control viremia (P = 0.0003). Protective HLA class I alleles were not enriched in these early HIV controllers, but viral sequencing revealed a significantly higher prevalence of drug resistance mutations associated with impaired viral fitness in controllers than in noncontrollers (6/15 [40.0%] versus 10/80 [12.5%], P = 0.018). Moreover, of two HLA-B57-positive (B57(+)) controllers identified, both harbored, at the earliest time point tested, signature escape mutations within Gag that likewise impair viral replication capacity. Only five controllers did not express "protective" alleles or harbor viruses with drug resistance mutations; intriguingly, two of them displayed typical B57 signature mutations (T242N), suggesting the acquisition of attenuated viruses from B57(+) donors. These data indicate that acute/early stage viruses from persons who become controllers have evidence of reduced replication capacity during the initial stages of infection which is likely associated with transmitted or acquired CTL escape mutations or transmitted drug resistance mutations. These data suggest that viral dynamics during acute infection have a major impact on HIV disease outcome.
引用
收藏
页码:7581 / 7591
页数:11
相关论文
共 60 条
[21]   HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control [J].
Emu, Brinda ;
Sinclair, Elizabeth ;
Hatano, Hiroyu ;
Ferre, April ;
Shacklett, Barbara ;
Martin, Jeffrey N. ;
McCune, J. M. ;
Decks, Steven G. .
JOURNAL OF VIROLOGY, 2008, 82 (11) :5398-5407
[22]   HIV-R viral escape in infancy followed by emergence of a variant-specific CTL response [J].
Feeney, ME ;
Tang, YH ;
Pfafferott, K ;
Roosevelt, KA ;
Draenert, R ;
Trocha, A ;
Yu, XG ;
Verrill, C ;
Allen, T ;
Moore, C ;
Mallal, S ;
Burchett, S ;
McIntosh, K ;
Pelton, SI ;
St John, AA ;
Hazra, R ;
Klenerman, P ;
Altfeld, M ;
Walker, BD ;
Goulder, PJR .
JOURNAL OF IMMUNOLOGY, 2005, 174 (12) :7524-7530
[23]   HLA-B63 presents HLA-B57/B58-restricted cytotoxic T-lymphocyte epitopes and is associated with low human immunodeficiency virus load [J].
Frahm, N ;
Adams, S ;
Kiepiela, P ;
Linde, CH ;
Hewitt, HS ;
Lichterfeld, M ;
Sango, K ;
Brown, NV ;
Pae, E ;
Wurcel, AG ;
Altfeld, M ;
Feeney, ME ;
Allen, TM ;
Roach, T ;
St John, MA ;
Daar, ES ;
Rosenberg, E ;
Korber, B ;
Marincola, F ;
Walker, BD ;
Goulder, PJR ;
Brander, C .
JOURNAL OF VIROLOGY, 2005, 79 (16) :10218-10225
[24]   Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients [J].
Goepfert, Paul A. ;
Lumm, Wendy ;
Farmer, Paul ;
Matthews, Philippa ;
Prendergast, Andrew ;
Carlson, Jonathan M. ;
Derdeyn, Cynthia A. ;
Tang, Jianming ;
Kaslow, Richard A. ;
Bansal, Anju ;
Yusim, Karina ;
Heckerman, David ;
Mulenga, Joseph ;
Allen, Susan ;
Goulder, Philip J. R. ;
Hunter, Eric .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (05) :1009-1017
[25]   Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS [J].
Goulder, PJR ;
Phillips, RE ;
Colbert, RA ;
McAdam, S ;
Ogg, G ;
Nowak, MA ;
Giangrande, P ;
Luzzi, G ;
Morgan, B ;
Edwards, A ;
McMichael, AJ ;
RowlandJones, S .
NATURE MEDICINE, 1997, 3 (02) :212-217
[26]   Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility [J].
Harrigan, PR ;
Kinghorn, I ;
Bloor, S ;
Kemp, SD ;
Najera, I ;
Kohli, A ;
Larder, BA .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5930-5934
[27]   Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro [J].
Harrigan, PR ;
Bloor, S ;
Larder, BA .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3773-3778
[28]   A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection [J].
Hecht, Frederick M. ;
Wang, Lei ;
Collier, Ann ;
Little, Susan ;
Markowitz, Martin ;
Margolick, Joseph ;
Kilby, J. Michael ;
Daar, Eric ;
Conway, Brian ;
Holte, Sarah .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (06) :725-733
[29]   Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes [J].
Honeyborne, Isobella ;
Prendergast, Andrew ;
Pereyra, Florencia ;
Leslie, Alasdair ;
Crawford, Hayley ;
Payne, Rebecca ;
Reddy, Shabashini ;
Bishop, Karen ;
Moodley, Eshia ;
Nair, Kriebashnie ;
van der Stok, Mary ;
McCarthy, Noel ;
Rousseau, Christine M. ;
Addo, Marylyn ;
Mullins, James I. ;
Brander, Christian ;
Kiepiela, Photini ;
Walker, Bruce D. ;
Goulder, Philip J. R. .
JOURNAL OF VIROLOGY, 2007, 81 (07) :3667-3672
[30]   Evolution of AZT resistance in HIV-1:: The 41-70 intermediate that is not observed in vivo has a replication defect [J].
Jeeninga, RE ;
Keulen, W ;
Boucher, C ;
Sanders, RW ;
Berkhout, B .
VIROLOGY, 2001, 283 (02) :294-305